UPADACITINIB

UNII:	4RA0KN46E0
Type:	INGREDIENT SUBSTANCE
Formula:	C₁₇H₁₉F₃N₆O
Preferred Substance Name:	UPADACITINIB
InChIKey:	WYQFJHHDOKWSHR-MNOVXSKESA-N
GSRS Full Record:	4RA0KN46E0 i

1310726-60-3
(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide
(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-
ABBV-599 COMPONENT UPADACITINIB
ABT-494
UPADACITINIB [MI]
UPADACITINIB [ORANGE BOOK]
UPADACITINIB [USAN]
Upadacitinib
Upadacitinib [WHO-DD]
Upadacitinib anhydrous
upadacitinib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

UPADACITINIB

Synonyms and Mappings

Resources